Our coverage of Westwater Resources is updated following two material announcements: 1) vanadium deposits have been identified at the Coosa graphite project in Alabama and 2) the Company has filed an arbitration request with the recognized international investment panel, seeking relief from Turkey’s revocation of the Company’s uranium mining licenses. In our view, both announcements […]
Author: Crystal Equity Research
Updated Coverage – PreveCeutical Medical (PRVCF, PREV)
PreveCeutical Medical (PRVCF, PREV) is an early stage life sciences company with a focus on curative and therapeutic compounds based on natural substances. Recent announcements point to value creation by PreveCeutical in recent months. The research and development team has made significant progress with several projects. The updates appear to confirm the Company has been […]
Updated Coverage – Westwater Resources (WWR)
Coverage of Westwater Resources, Inc. (WWR) has been updated following report of financial performance in the quarter ending September 2018. Recent events in each of Westwater’s target markets demonstrate the large and growing market opportunities that have been a central part of our investment thesis in Westwater, continue to develop unabated. Perhaps more importantly the […]
Updated Coverage – PreveCeutical Medical, Inc. (PRVCF, PREV)
Early stage biotechnology company PreveCeutical Medical (PRVCF: OTC, PREV: CN) has made considerable progress with an ambitious research pipeline focused on preventative and curative medicines. The Company has claimed several achievements in recent months, moving projects “closer to goal.’ We have had high hopes for the Company in 2018, and so far we have not […]
Updated Coverage – Westwater Resources (WWR)
Westwater Resources reported a $20.5 million net loss in the quarter ending June 2018, including a one-time non-cash charge of $18.0 million for impairment of the Company’s uranium assets in Turkey. The accounting treatment was triggered by the revocation of licenses by the Turkish mining authority without any specified compensation figure. Concerns over the license […]